The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Prime Medicine, Inc.(NASDAQ:PRME)

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime...
Website: https://www.primemedicine.com
Founded: 2019
IPO Price: $17 (Oct 20, 2022)
Full Time Employees: 150
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Prime Medicine . Days Payable Outstanding ttm (DPO)
Prime Medicine . Op Cashflow Per Share ttm
Prime Medicine . Free Cashflow Per Share ttm
Prime Medicine . Cash Per Share ttm
Prime Medicine . P/S ratio ttm
Prime Medicine . (GAAP) P/E ratio ttm
Prime Medicine . P/B ratio ttm
No extra charts and metrics for this ticker.